151
Participants
Start Date
December 21, 2017
Primary Completion Date
May 21, 2021
Study Completion Date
February 23, 2023
Dexmedetomidine
The 4D trial is an investigator-initiated, prospective, multicenter, randomized, double-blinded, two-arm trial, randomizing 300 non-intubated ICU patients with diagnosis of agitated delirium to receive dexmedetomidine or placebo as a cure
Placebo
The 4D trial is an investigator-initiated, prospective, multicenter, randomized, double-blinded, two-arm trial, randomizing 300 non-intubated ICU patients with diagnosis of agitated delirium to receive dexmedetomidine or placebo as a cure
CHU Clermont-Ferrand, Clermont-Ferrand
University Hospital, Clermont-Ferrand
OTHER